Jason A Mouabbi

6PUBLICATIONS
17CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 22, 2025
Human Epidermal Growth Factor Receptor 2 Loss following Treatment with Trastuzumab Deruxtecan in Patients with Metastatic Breast Cancer.

Mohamed A Gouda, Amrit Gonugunta, Ecaterina E Dumbrava

|Dec 20, 2022
Histology-based survival outcomes in hormone receptor-positive metastatic breast cancer treated with targeted therapies.

Jason A Mouabbi, Akshara Singareeka Raghavendra, Roland L Bassett

|Mar 29, 2022
Invasive lobular carcinoma: an understudied emergent subtype of breast cancer.

Jason A Mouabbi, Amy Hassan, Bora Lim

|Sep 13, 2021
Management of hormone receptor-positive, human epidermal growth factor 2-negative metastatic breast cancer.

Jason A Mouabbi, C Kent Osborne, Rachel Schiff

Pageof 1